Work

Sunovion Pharmaceuticals Europe Announce the European Marketing Authorisation for Latuda ® ▼ (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia

Year: 2014
Type: article
Author: Andrea Hall
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2551414105
FWCI:
Cites: 7
Cited by:
Related to: 10